A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Lumos Pharma
Massachusetts General Hospital
Washington University School of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radiation Therapy Oncology Group
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
City of Hope Medical Center
NYU Langone Health
Case Comprehensive Cancer Center